Related references
Note: Only part of the references are listed.FDG PET or PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma A Systematic Review and Meta-analysis
Yu-Yu Lu et al.
CLINICAL NUCLEAR MEDICINE (2012)
Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms
Riccardo Ferdani et al.
DALTON TRANSACTIONS (2012)
Content Development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): Use of Qualitative and Quantitative Methods for Scale Construction
Lynne I. Wagner et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma
Allison L. Zwingenberger et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma
Noopur Raje et al.
CLINICAL CANCER RESEARCH (2011)
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management
Sigurdur Y. Kristinsson et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
Antonio Palumbo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Essential roles of VLA-4 in the hematopoietic system
Yoichi Imai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Adhesion molecules-The lifelines of multiple myeloma cells
Ben-Zion Katz
SEMINARS IN CANCER BIOLOGY (2010)
Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1α and MIP-1β production
Masahiro Abe et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Activated Integrin VLA-4 Localizes to the Lamellipodia and Mediates T Cell Migration on VCAM-1
Young-Min Hyun et al.
JOURNAL OF IMMUNOLOGY (2009)
Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
K. Noborio-Hatano et al.
ONCOGENE (2009)
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma
Rosa Fonti et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
PET/CT and MR imaging in myeloma
Michael E. Mulligan et al.
SKELETAL RADIOLOGY (2007)
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma
Richard J. Breyer et al.
SKELETAL RADIOLOGY (2006)
Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging
Li Peng et al.
NATURE CHEMICAL BIOLOGY (2006)
The role of anatomic and functional staging in myeloma: Description of Durie/Salmon PLUS staging system
Brian G. M. Durie
EUROPEAN JOURNAL OF CANCER (2006)
Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma
K Orchard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Metabolic flare: Indicator of hormone responsiveness in advanced breast cancer
JE Mortimer et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
VLA-4-dependent myeloma cell adhesion
F Sanz-Rodríguez et al.
LEUKEMIA & LYMPHOMA (2001)
Resolution and noise properties of MAP reconstruction for fully 3-D PET
JY Qi et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2000)
Share Paper
